Skip to main content
. 2020 Mar 17;12:153–166. doi: 10.2147/CEOR.S234385

Table 7.

Cost-Effectiveness Analysis

Test Mean Lifetime Cost of Management Per Subject Probability of Detecting: Difference in Management Cost Difference in Probability of Detecting: Incremental Cost for Each Additional:
A true
Positive
A Subject in CIN3 A True Positive A Subject in CIN3 True Positive Detected Subject Diagnosed with CIN3
Discounted costs
CC €7,523 0.022 0.011
LBC €4,852 0.038 0.019 -€2,671 0.016 0.008 Dominant (-€166,938) Dominant (-€333,875)
Undiscounted costs
CC €21,038 0.022 0.011
LBC €13,022 0.038 0.019 -€8016 0.016 0.008 Dominant (-€501,000) Dominant (-€1,002,000)